WELL Health Technologies Corp (WELL – Research Report) has received a rating update from a Wall Street analyst today. Analyst Justin Keywood from Stifel Nicolaus remains bullish on the stock and has a C$11.00 price target.
According to TipRanks.com, Keywood is a 2-star analyst with an average return of -0.2% and a 39.3% success rate. Keywood covers the Healthcare sector, focusing on stocks such as Andlauer Healthcare Group, Cipher Pharmaceuticals, and Knight Therapeutics.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for WELL Health Technologies Corp with a C$8.42 average price target, a 121.0% upside from current levels. In a report issued on November 16, Laurentian Bank of Canada also maintained a Buy rating on the stock with a C$6.50 price target.
Based on WELL Health Technologies Corp’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of C$171 million and GAAP net loss of C$5.77 million. In comparison, last year the company earned revenue of C$140 million and had a GAAP net loss of C$12.17 million.
WELL Health Technologies Corp is the owner and operator of a portfolio of Primary Hclinics delivering healthcare-related services It operates through below segments: Clinical services, Digital services, and others. It also engages in the Electronic Medical Records business that supports the digitization of clinics. Its objective is to empower doctors to provide the best and most advanced care possible leveraging the latest trends in digital health.
The company’s shares closed last Thursday at C$3.80.
Read More on TSE:WELL:
- WELL Health Reports Record Results for Q3-2023, Raises Guidance for Balance of 2023 and Provides Guidance of Over $900 Million in Revenue for 2024
- WELL Upcoming Earnings Report: What to Expect?
- WELL Health’s Cycura Announces Two Tuck-In Acquisitions to Enhance Patient Data Protection and Appoints New Management
- WELL Health Completes Clinic Acquisition and Investment Transactions with HEALWELL AI Inc. (formerly MCI Onehealth), and Forms Strategic Alliance Focused on Developing AI Enabled Disease Detection and Preventative Care Tools for Care Providers
